Bottom line
HTEC vs PBE: the short answer
HTEC (ROBO Global(R) Healthcare Technology and Innovation ETF) and PBE (Invesco Biotechnology & Genome ETF) are both etfs.
PBE is cheaper at 0.59% vs 0.68% — a difference of $9.00 a year per $10,000 invested.
Over five years, PBE returned +3.4% a year vs −3.9% for HTEC.
Updated Nov 19, 2026
HTEC vs PBE side by side
| HTEC | PBE | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Innovator | Invesco |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.68% | 0.59% |
| Annual cost per $10k | $68 | $59 |
| 10-yr cost on $10k (prospectus) | $979 | $738 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +24.0% | +24.7% |
| 5-yr return (annualized) | −3.9% | +3.4% |
| 10-yr return (annualized) | — | +5.2% |
| Best quarter | +30.7% | +25.3% |
| Worst quarter | −20.8% | −24.3% |
| Net assets (fund) | $69.1M | $281.9M |
| Number of holdings | 63 | 33 |
| Portfolio turnover | 38% | 103% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HTEC | PBE | Difference |
|---|---|---|---|
| 2025 | +24.0% | +24.7% | −0.7% |
| 2024 | +2.8% | +1.1% | +1.7% |
| 2023 | −3.0% | +3.7% | −6.7% |
| 2022 | −33.6% | −10.8% | −22.8% |
| 2021 | −0.2% | +1.6% | −1.8% |
| 2020 | +65.2% | +25.5% | +39.7% |
Source: Fund prospectus bar charts
Holdings overlap
5 of HTEC's top 25 holdings also appear in PBE's top 25.
| Holding | HTEC | PBE |
|---|---|---|
| Caredx, Inc. | 2.68% | 5.04% |
| Illumina, Inc. | 2.09% | 3.51% |
| Regeneron Pharmaceuticals, Inc. | 1.97% | 5.47% |
| Vertex Pharmaceuticals Incorporated | 1.91% | 4.99% |
| Incyte Corporation | 1.80% | 3.06% |
Source: SEC Form N-PORT
HTEC top 10
- Caredx, Inc. — 2.68%
- Guardant Health, Inc. — 2.31%
- Natera, Inc. — 2.23%
- Twist Bioscience Corp — 2.23%
- Thermo Fisher Scientific Incorporated — 2.18%
- Medpace Holdings, Inc. — 2.12%
- Adaptive Biotechnologies Corporation — 2.11%
- Iqvia Holdings Inc — 2.10%
- Illumina, Inc. — 2.09%
- Arrowhead Pharmaceuticals, Inc. — 2.08%
PBE top 10
- Invesco Private Prime Fund — 12.89%
- Regeneron Pharmaceuticals, Inc. — 5.47%
- Amgen Inc. — 5.22%
- CareDx, Inc. — 5.04%
- Vertex Pharmaceuticals Inc. — 4.99%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Biogen Inc. — 4.79%
- Gilead Sciences, Inc. — 4.43%
- United Therapeutics Corp. — 4.08%
FAQ
What is the difference between HTEC and PBE?
Which is cheaper, HTEC or PBE?
Should I own both HTEC and PBE?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.